Not applicableWithdrawnNCT00898612What this trial is testingEarly Detection of Graft-Versus-Host Disease in Patients Undergoing a Donor Bone Marrow TransplantWho this might be right forLymphoma Mayo Clinic
Testing effectiveness (Phase 2)Ended earlyNCT01220128What this trial is testingEvaluation of an Anti-cancer Immunotherapy Combined With Standard Neoadjuvant Treatment in Patients With WT1-positive Primary Invasive Breast CancerWho this might be right forNeoplasms, Breast GlaxoSmithKline 66
Large-scale testing (Phase 3)Study completedNCT00179829What this trial is testingWT1 for the Detection of Minimal Residual DiseaseWho this might be right forLeukemiaCancer Ann & Robert H Lurie Children's Hospital of Chicago 50
Large-scale testing (Phase 3)Study completedNCT00008359What this trial is testingCaspofungin Acetate Compared With Amphotericin B Liposomal in Treating Patients With Persistent Fever and Neutropenia Following Cancer TreatmentWho this might be right forCancer Memorial Sloan Kettering Cancer Center
Early research (Phase 1)Ended earlyNCT00672152What this trial is testingA Phase I Study of WT1 Peptides to Induce Anti-Leukemia Immune Responses Following TransplantationWho this might be right forAcute Myelogenous Leukemia (AML)Chronic Myelogenous Leukemia (CML)Acute Lymphoblastic Leukemia (ALL)+2 more Michael Morse, MD 8
Testing effectiveness (Phase 2)Ended earlyNCT00617929What this trial is testingAntithymocyte Globulin, Clofarabine, and Rituximab in Treating Patients After an Unsuccessful Stem Cell TransplantWho this might be right forCancer Masonic Cancer Center, University of Minnesota 12
Not applicableStudy completedNCT02016833What this trial is testingDevelopment of Immunological Assays for the Evaluation of Tumor Antigen Specific ImmunityWho this might be right forOvarian Serous AdenocarcinomaUndifferentiated Carcinoma of OvaryCervical Cancer+3 more PX Biosolutions 15
Testing effectiveness (Phase 2)UnknownNCT01513109What this trial is testingSafety and Immunogenicity of Recombinant WT1 Antigen-Specific Cancer Immunotherapeutic Combined With Infusion of Treg Depleted T Cells for Adult WT1 Acute Myeloid LeukemiaWho this might be right forAcute Myelogenous LeukemiaMyeloid Leukemia in RemissionEffects of Immunotherapy Jules Bordet Institute 20
Testing effectiveness (Phase 2)Study completedNCT00003408What this trial is testingBiological Therapy Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With CancerWho this might be right forBreast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more Cancer Treatment Centers of America 40
Early research (Phase 1)Study completedNCT00270452What this trial is testingSafety of Peptide Vaccination for Patients With Myelodysplastic SyndromeWho this might be right forMyelodysplastic Syndrome (MDS) National Heart, Lung, and Blood Institute (NHLBI) 9
Early research (Phase 1)Looking for participantsNCT06198296What this trial is testingImmunotherapy For Adults With GPC3-Positive Solid Tumors Using IL-15 and IL-21 Armored GPC3-CAR T CellsWho this might be right forHepatoblastomaHepatocellular CarcinomaWilms Tumor+5 more Baylor College of Medicine 21
Not applicableStudy completedNCT00003538What this trial is testingPrevention of Graft-Versus-Host Disease in Patients Undergoing Bone Marrow TransplantationWho this might be right forCancer Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Testing effectiveness (Phase 2)Study completedNCT00066599What this trial is testingVoriconazole in Preventing Fungal Infections in Children With Neutropenia After ChemotherapyWho this might be right forKidney CancerLeukemiaLymphoma+6 more National Cancer Institute (NCI)
Not applicableEnded earlyNCT00949052What this trial is testingGenetic Susceptibility and Risk of Second Cancers in Patients Who Have Undergone Stem Cell Transplant for CancerWho this might be right forCancer Vanderbilt-Ingram Cancer Center 1,000
Early research (Phase 1)UnknownNCT00769613What this trial is testingEmergency Use of Donor Lymphocytes in Treating Patients Who Have Undergone Donor Stem Cell Transplant and Have Cytomegalovirus InfectionsWho this might be right forCancer Milton S. Hershey Medical Center 20
Large-scale testing (Phase 3)Study completedNCT00014391What this trial is testingRibavirin With or Without Monoclonal Antibody Therapy in Treating Patients Who Develop RSV Pneumonia Following Peripheral Stem Cell TransplantationWho this might be right forCancer Fred Hutchinson Cancer Center
Early research (Phase 1)Study completedNCT00509691What this trial is testingVaccine Therapy in Treating Patients Who Have Undergone a Donor Stem Cell Transplant and Have Cytomegalovirus Infection That Has Not Responded to TherapyWho this might be right forCancer University of Louisville 20
Early research (Phase 1)Study completedNCT00003107What this trial is testingInterleukin-12 in Treating Patients With Hematologic Cancers or Solid TumorsWho this might be right forBreast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+8 more Indiana University School of Medicine
Early research (Phase 1)Study completedNCT05360680What this trial is testingIn Patients With HLA-A*0201+ and WT1+ Recurrent/Metastatic CancersWho this might be right forColorectal CancerGastric CancerPancreatic Cancer+1 more Cue Biopharma 42
Early research (Phase 1)Study completedNCT00030108What this trial is testingIxabepilone in Treating Young Patients With Solid Tumors or Leukemia That Haven't Responded to TherapyWho this might be right forBrain and Central Nervous System TumorsChildhood Germ Cell TumorExtragonadal Germ Cell Tumor+7 more National Institutes of Health Clinical Center (CC) 30